mitomycin has been researched along with Adamantiades-Behcet Disease in 4 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Excerpt | Relevance | Reference |
---|---|---|
"To examine clinical outcomes following an initial trabeculectomy with mitomycin-C for secondary glaucoma associated with uveitis in Behçet disease (BD) patients." | 7.85 | Initial Trabeculectomy With Mitomycin-C for Secondary Glaucoma-associated With Uveitis in Behçet Disease Patients. ( Aihara, M; Fujino, Y; Kaburaki, T; Komae, K; Matsuda, J; Nakahara, H; Ohtomo, K; Okinaga, K; Takamoto, M; Tanaka, R, 2017) |
"To determine the outcome of initial trabeculectomy with mitomycin C (MMC) in the management of secondary glaucoma associated with Behçet disease (BD) in a 1-year follow-up period." | 7.74 | Trabeculectomy with mitomycin C in secondary glaucoma associated with Behçet disease. ( Batman, A; Berker, N; Elgin, U; Soykan, E, 2007) |
"To determine the effect of intraoperative application of Mitomycin-C (MMC) with trabeculectomy in uveitic glaucoma associated with Behçet disease." | 7.72 | Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Behçet disease. ( Duman, S; Eksioglu, U; Sungur, G; Turhan, E; Yalvac, IS, 2004) |
"To examine clinical outcomes following an initial trabeculectomy with mitomycin-C for secondary glaucoma associated with uveitis in Behçet disease (BD) patients." | 3.85 | Initial Trabeculectomy With Mitomycin-C for Secondary Glaucoma-associated With Uveitis in Behçet Disease Patients. ( Aihara, M; Fujino, Y; Kaburaki, T; Komae, K; Matsuda, J; Nakahara, H; Ohtomo, K; Okinaga, K; Takamoto, M; Tanaka, R, 2017) |
"To determine the outcome of initial trabeculectomy with mitomycin C (MMC) in the management of secondary glaucoma associated with Behçet disease (BD) in a 1-year follow-up period." | 3.74 | Trabeculectomy with mitomycin C in secondary glaucoma associated with Behçet disease. ( Batman, A; Berker, N; Elgin, U; Soykan, E, 2007) |
"To determine the effect of intraoperative application of Mitomycin-C (MMC) with trabeculectomy in uveitic glaucoma associated with Behçet disease." | 3.72 | Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Behçet disease. ( Duman, S; Eksioglu, U; Sungur, G; Turhan, E; Yalvac, IS, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Komae, K | 1 |
Takamoto, M | 1 |
Tanaka, R | 1 |
Aihara, M | 1 |
Ohtomo, K | 1 |
Okinaga, K | 1 |
Matsuda, J | 1 |
Nakahara, H | 1 |
Fujino, Y | 1 |
Kaburaki, T | 1 |
Yalvac, IS | 1 |
Sungur, G | 1 |
Turhan, E | 1 |
Eksioglu, U | 1 |
Duman, S | 1 |
Elgin, U | 1 |
Berker, N | 1 |
Batman, A | 1 |
Soykan, E | 1 |
Peavy, DL | 1 |
Nelms, DC | 1 |
Mackler, BF | 1 |
4 other studies available for mitomycin and Adamantiades-Behcet Disease
Article | Year |
---|---|
Initial Trabeculectomy With Mitomycin-C for Secondary Glaucoma-associated With Uveitis in Behçet Disease Patients.
Topics: Adult; Alkylating Agents; Behcet Syndrome; Combined Modality Therapy; Conjunctiva; Female; Glaucoma; | 2017 |
Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Behçet disease.
Topics: Adolescent; Adult; Aged; Behcet Syndrome; Chemotherapy, Adjuvant; Female; Glaucoma; Humans; Intraocu | 2004 |
Trabeculectomy with mitomycin C in secondary glaucoma associated with Behçet disease.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antihypertensive Agents; Behcet Syndrome; Combined M | 2007 |
Failure of autologous oral epithelia to activate RAS lymphocytes.
Topics: Behcet Syndrome; Epithelial Cells; Epithelium; Humans; Lymphocyte Activation; Mitomycin; Mitomycins; | 1982 |